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Abstract: Autism spectrum disorder (ASD) is a complex set of neurodevelopmental pathologies char-
acterized by impoverished social and communicative abilities and stereotyped behaviors. Although
its genetic basis is unquestionable, the involvement of environmental factors such as exposure to
pesticides has also been proposed. Despite the systematic analyses of this relationship in humans,
there are no specific reviews including both human and preclinical models. The present systematic re-
view summarizes, analyzes, and discusses recent advances in preclinical and epidemiological studies.
We included 45 human and 16 preclinical studies. These studies focused on Organophosphates (OP),
Organochlorine (OC), Pyrethroid (PT), Neonicotinoid (NN), Carbamate (CM), and mixed exposures.
Preclinical studies, where the OP Chlorpyrifos (CPF) compound is the one most studied, pointed to
an association between gestational exposure and increased ASD-like behaviors, although the data
are inconclusive with regard to other ages or pesticides. Studies in humans focused on prenatal
exposure to OP and OC agents, and report cognitive and behavioral alterations related to ASD
symptomatology. The results of both suggest that gestational exposure to certain OP agents could
be linked to the clinical signs of ASD. Future experimental studies should focus on extending the
analysis of ASD-like behaviors in preclinical models and include exposure patterns similar to those
observed in human studies.
Keywords: autism spectrum disorder; sociability; pesticide; organophosphate; carbamates; organochlo-
rine; chlorpyrifos
1. Introduction
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental
disorders characterized by varying degrees of altered sociability, reduced communicative
skills, and repetitive stereotyped behaviors unfocused on a specific goal [1]. Although these
constitute the core clinical signs of ASD, it is well-known that ASD-diagnosed children
also display alterations in other physical and cognitive functions such as motricity [2],
attention [3], memory [4], and inhibitory control [5], amongst others.
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Although the etiopathology of ASD remains unknown, there is a consensus regarding
the relevance of its heritable/genetic basis, confirmed in various human twin studies [6]
and animal models that show a simplified ASD-like phenotype, as in the case of the
fragile X mental retardation (FMR1)-KO rodents, the BTBR models, and the neuroligin 3
(Nlgn3)-KO rodents, amongst others [7]. There is considerable empirical support for this
genetic component [8], with multiple genes and loci found to be strongly associated with
the diagnosis of ASD, of which the matrix metallopeptidase 12, neurotrimin, potassium
calcium-activated channel subfamily N member 2, and the microtubule-associated protein
tau are particularly noteworthy. However, the prevalence of ASD has increased significantly
in recent decades [9], which can presumably be taken to indicate that heritability and genetic
background are not the only causes of this set of disorders. This impressive rise in the
prevalence of ASD diagnoses can be partially explained by changes in diagnostic criteria
(for a good example, see [10]).
Although the impact of these changes is unquestionable, this factor is not able to
explain completely this sharp rise in diagnoses. Other authors have proposed that the
incidence of external factors could interact with the developmental central nervous system
(CNS) by inducing physiological and functional abnormalities linked to the development of
ASD and/or its degree of severity [11]. In general, the etiology of ASD is considered from a
multifaceted perspective, where the relevant genes play an important role as vulnerability
factors that are modulated by external environmental variables influencing the course
and severity of the final behavioral and molecular outputs observed in the diagnosed
patients [12]. Some of the most significant environmental factors are perinatal stressors,
infections, socioeconomic status, dysfunctional familiar relations, and exposure to specific
agents with a neurotoxic profile [11,12]. From the latter category, the most important toxic
compounds linked to ASD are heavy metals, persistent organic pollutants, and valproic
acid (VPA) [13], along with exposure to pesticides [14–16]. These aspects make the study of
ASDs particularly suitable to new research approaches such as those included in exposome
science [17]. Developments in exposome science have revealed the need for evaluating the
interrelationships among phenotype, genotype, and exposure data (expotype).
Concerning neurotoxic agents, various families of pesticides have recently been linked
with ASD. Of these, Organochlorine (OC), Pyrethroids (PT), Carbamates (CM), Neoni-
cotinoids (NN), and Organophosphates (OP) have been studied in most depth. Briefly,
OC compounds are synthetic pesticides widely used globally, with important applications
in both industry and agriculture and whose main mechanisms of toxicity are the regulation
of the axonal sodium gates (DDT-Type) and GABAergic regulation of Chloride ion influxes
(Chlorinated Alicyclic-type) [18]. Some of the most important OC agents are DDT, DDD,
Eldrin, Dieldrin, and Endosulfan, amongst others [19]. Moreover, PT agents are compounds
commonly used as insecticides that induce excitatory paralysis by directly acting on the
voltage-gated sodium channels [20]. Some of the most representative PT compounds are
Allethrin, Dimethrin, Tetramethin, and Alphametrin [19]. CM xenobiotic compounds gen-
erally induce their toxic profile by reversibly inhibiting the Acetylcholinesterases (AChE),
thus increasing the cholinergic tone in the CNS [21]. From this chemical family, Carbaryl,
Aldicarb, Pyrolan, and Carbanolate are among the most notable methyl agents [19]. Added
to this, NN xenobiotic agents are a group of effective insecticides whose main use is fo-
cused on the control of sucking insects and flea control, since they act as selective agonists
of nicotinic receptors [22]. Of these, Imidacloprid, Thiamethoxam, and Clothianidin are
among the most used [22]. Finally, OP compounds are a wide-range group of pesticides
commonly applied in industry, agriculture, and, to a less extent, used for residential pur-
poses [23]. Their main mechanism of toxicity is the irreversible inhibition of the AChE
in the CNS. Some of the most noteworthy OP agents are Chlorpyrifos (CPF), Malathion
(MAL), Parathion, and Tricholorfan [19].
Both human and rodent studies have found interesting links between exposure to
these various pesticides and ASD diagnosis or ASD-like behaviors [24,25]. However,
results differ depending on the agent, the dose, the time of exposure, age of behavioral
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assessment, and the outcomes measured. Thus, whilst it appears that we have sufficient
empirical results to establish solid conclusions, this is not actually the case, since the
different studies have not been adequately analyzed based on the specific characteristics
previously defined. Moreover, there is a lack of adequate discussion regarding the quality
of each individual study.
Given these considerations, we thought it worthwhile to conduct a systematic review
of the most important empirical studies concerning exposure to different pesticides and
their effect on ASD diagnosis and core behaviors in humans, and on ASD-like outcomes
in pre-clinical rodent models. In doing so, the scientific community will have access to
a clearer picture of the real relationship between exposure to these compounds and the
incidence of ASD.
2. Materials and Methods
2.1. Review Protocol
Prior to the literature search and in accordance with the ‘’Preferred Reporting Items for
Systematic Review and Meta-Analysis Protocol” (PRISMA-P) Moher et al. [26] a detailed
review protocol was created. As recommended by the PRISMA-P guidelines, and according
to the suggestions of the PROSPERO reviewers, two registrations were created on the
PROSPERO database: one for animals (Prospero-ID: 145135, October 2019) and one for
humans (Prospero ID: 153081, October 2019).
2.2. Eligibility Criteria
The systematic review was structured initially with the aid of the PICOS acronym
(Participants, Interventions, Comparators, Outcomes measures, Study design). Participants
were young humans (children or adolescents) and rodents. Interventions were prenatal or
postnatal exposures to potential neurotoxic pesticides, herbicides, or insecticides. Moreover,
comparison of environmental exposure (pre or postnatal) to pesticides, herbicides, or insec-
ticides with a control/non-exposed group or comparison between groups with different
levels of exposure (i.e., low, medium, high) were assessed according to the proximity to
agricultural/industrial areas or the metabolite levels in blood/urine samples.
Biological outcomes such as agent exposure biomarkers (metabolite levels in blood or
urine samples), hormonal alterations (enzymatic analyses in blood or urine), neurotrans-
mitter activity alterations (protein levels in immunochemical arrays of blood and tissue
samples and genetic expression in PCR), and cytokine alterations (protein levels in im-
munochemical arrays of blood and tissue samples) were assessed. Furthermore, behavioral
measures related to autism such as cognitive and psychomotor alterations, as well as social
communication impairments, were also evaluated.
In addition, experimental studies in the literature with animal models and cohort,
cross-sectional and case-control human studies were considered, along with studies written
in English and published within the last ten years. Exclusion criteria were defined by
considering those aspects that did not meet the previously defined PICOS characteristics.
Therefore, we did not select case studies, reviews, abstracts, or communications at scientific
meetings, or qualitative studies. Lastly, we only included articles published in peer-
reviewed journals.
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2.3. Information Sources
We carried out comprehensive literature searches of Pubmed and Scopus until March
2020. The keywords used were autism spectrum disorder (ASD), pesticides, insecticides,
herbicides, gestational, prenatal, and postnatal exposure, neurodevelopment, humans (plus
combinations). Filters employed in the database searches were language (English) and data
publication (last ten years). The search formula was: (TITLE-ABS-KEY (pesticides) AND
(TITLE-ABS-KEY (prenatal AND expos*) OR TITLE-ABS-KEY (postnatal AND expos*) OR
TITLE-ABS-KEY (gestational AND expos*) AND TITLE-ABS-KEY (autism*) OR TITLE-
ABS-KEY (ASD) OR TITLE-ABS-KEY (neurodevelopment*). In Scopus, an asterisk served
as a substitute for any number of characters, expanding the search. Furthermore, a hand-
search was performed in relevant journals and the reference lists of reviews focusing on
the subject.
2.4. Study Selection and Data Collection Process
After eliminating duplicates, one reviewer examined the complete list of results for
eligibility. If further relevant decisions were to be made, these were discussed among
the research team until reaching a consensus. Moreover, two reviewers independently
extracted the data in an unblended manner. Any disagreements were resolved until
achieving consensus.
2.5. Risk of Bias in Individual Studies
Two tools were employed to assess the risk of bias: for animal studies, we used the
‘’SYRCLE’s tool for assessing the risk of bias” [27], which is an adaptation for animal studies
based on the Cochrane collaborations RoB tool [28], whilst for human studies, we employed
the Newcastle-Ottawa Scale (NOS) to rate cohort and case-control studies [29].
In this regard, the SYRCLE consists of five quality parameters: selection, performance,
detection, attrition, and reporting bias. It assigns a maximum of six points for selection,
four points for performance, four points for detection, four points for attrition, and four
points for reporting (for a total of 18 points). Therefore, the total quality index score was
ranked as follows: 0 to 3, 4 to 6, 7 to 9, 10 to 12, 13 to 15, and 16 to 18, these being very
low (VL), low (L), medium-low (ML), medium-high (MH), high (H), and very high (VH)
quality, respectively. For human studies, the NOS uses three quality parameters: selection,
comparability, and exposure/outcome assessment. It assigns a maximum of four points for
selection, two points for comparability, and three points for exposure or outcome (making
a total of 9 points). Hence, the total quality index score was ranked as follows: 0 to 2, 3 to 4,
5 to 6, and 7 to 9, these being L, MH, H, and VH quality, respectively.
3. Results
3.1. Selection of Studies
A flow diagram illustrates the whole search strategy (Figure 1). The first screening
provided a total of 464 studies, and after removing duplicates and selecting articles based
on year, language, and exclusion of reviews, a total number of 170 articles were selected.
Further, 7 preclinical and 43 clinical studies were eliminated after reviewing the title and
abstract. A parallel search based on words mentioned previously allowed us to find a
further nine preclinical and two clinical studies. Thus, 16 preclinical and 45 clinical studies
comprised the total number of studies included in this review.
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Figure 1. Flow Diagram. From top to bottom, the total number of outputs from Scopus and PubMed searches (n = 464). 
Selection based on year, language (n = 308) and exclusion of duplicates (n = 194), the total number of studies that success-
fully passed the selection checklist (n = 50), and the total number of accepted studies after parallel searching (n = 61). 
3.2. Search Results and General Quality 
Sixteen preclinical and 45 clinical studies were accepted. With regard to the studies 
conducted in rodents, the majority exposed the animals to CPF or CPO (11 out of 16, 
68.5e%) [30–40]. A further two studies used other OP compounds such as CPF, MAL [41], 
and Phosphomedon (PMD) [42]. That is, most of the studies included in the present re-
view are concerned with OP exposure (13 out of 16, 81.3%). Of the remaining articles, two 
used Glufosinate ammonium (GLA) (12.5%) [43,44], and one exposed their animals to the 
synthetic Pyrethroid cypermethrin (CYP) (6.3%) [45]. From all of these studies, only one 
[42] did not administer the pesticide during development; thus, most of the studies in-
cluded in this systematic review present good examples of developmental neurotoxicity 
(15 out of 16, 93.8%). Interestingly, 10 out of the 16 studies (62.5%) followed a gestational 
exposure protocol, two used postnatal exposure (12.5%), and three employed a continu-
ous exposure regime during both gestational and postnatal stages (18.8%). All of these 
studies, with the exception of the adult study, used mice models. Basaure et al. [40] also 
exposed their rodents to CPF during adulthood along with postnatal exposure. 
Regarding the studies conducted in humans, 17 out of 45 (37.8%) studied OP expo-
sure using urine, blood, and house-dust metabolite measures [46–62], with OP being the 
most studied pesticide in this review. From the remaining articles, 9 out of 45 (20.0%) 
studied OC exposure by DDT and/or DDE exposure [63–71], while Puertas et al. [72] and 
Boucher et al. [73] used other OC compounds such as Mirex and Chlordecone, respec-
tively. Thus 11 out of 45 (24.4%) of the total studies were related to OC exposure. Further, 
Figure 1. Flow Diagram. From top to bottom, the total number of outputs from Scopus and PubMed searches (n = 464).
Selection based on year, language (n = 308) and exclusio of duplicates (n = 194), the total number of studi s that successfully
passed the selection checklist (n = 50), and the total number of ac epted studies after p rallel searching (n = 61).
3.2. Search Results and General Quality
Sixteen preclinical and 45 clinical studies were accepted. With regard to the studies
conduct d in rodents, the major ty expos d the animals to CPF or CPO (11 out of 16,
68.5e%) [30–40]. A fur r tw studies u other OP compounds such as CPF, MAL [41],
and Phosphomedon (PMD) [42]. That is, most of the studie in luded in the present
review are concer ed with OP exposure (13 out of 16, 81.3%). Of the remaining articles,
two used Glufosinate ammonium (GLA) (12.5%) [43,44], and one exposed their animals
to the synthetic Pyrethroid cypermethrin (CYP) (6.3%) [45]. From all of these studies,
only one [42] did not administer the pesticide during development; thus, most of the studies
included in this systematic review present good examples of developmental neurotoxicity
(15 out of 16, 93.8%). Interestingly, 10 out of the 16 studies (62.5%) followed a gestational
exposure protocol, two used postnatal exposure (12.5%), and three employed a continuous
exposure regime during both gestational and postnatal stages (18.8%). All of these studies,
with the exception of the adult study, used mice models. Basaure et al. [40] also exposed
their rodents to CPF during adulthood along with postnatal exposure.
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Regarding the studies conducted in humans, 17 out of 45 (37.8%) studied OP expo-
sure using urine, blood, and house-dust metabolite measures [46–62], with OP being the
most studied pesticide in this review. From the remaining articles, 9 out of 45 (20.0%)
studied OC exposure by DDT and/or DDE exposure [63–71], while Puertas et al. [72] and
Boucher et al. [73] used other OC compounds such as Mirex and Chlordecone, respectively.
Thus 11 out of 45 (24.4%) of the total studies were related to OC exposure. Further, PT ex-
posure was assessed in 3 out of 45 studies (6.7%) [74–76], whereas exposure to Permethrin,
and Piperonyl butoxide (PBO) (a synergistic component of pesticide formulation) and
the metabolite of PT insecticide 3-phenoxybenzoic acid (3-PBA) exposure were reported
by Horton et al. [77] and Watkins et al. [78], being five (11.1%) the total PT studies. Ad-
ditionally, Zhang et al. [79] and Mora et al. [80] used Carbofuranphenol and Mancozeb
compounds to assess CM exposure, whereas Keil et al. [81] assessed Imidacloprid exposure,
a NN pesticide. Finally, 9 out of 45 (20.0%) studies [82–90] reported exposure to a common
mix of different types of pesticides. From all these studies, 37 out of 45 (82.2%) followed
a longitudinal design, while only 8 (17.8%) were case-control studies. Moreover, 32 out
of 45 (71.1%) defined a prenatal exposure period, two (4.4%) a postnatal exposure period,
while the remaining 11 (24.4%) considered both prenatal and postnatal periods. In human
studies, exposure outcomes were assessed during childhood or adolescence.
Concerning the quality of the preclinical studies, three out of the 16 were labeled as
H (18.8%) [30,37,38], 10 as MH (62.5%) [31–36,40,43–45], and the remaining three as ML-
quality (18.8%) [39,41,42]. In a similar vein, 37 out of 45 human studies were classified as VH
(82.2%) [46,48–53,56–59,61,63–67,70–77,80–85,87–91], 7 as H (15.6%) [47,54,55,60,68,69,78]
and only Woskie et al. [62] was classified as MH-quality.
3.3. Pesticide Exposure and ASD-Like Outcomes: Preclinical Studies
All of the preclinical studies concerned with pesticide exposure and ASD-like behav-
iors are summarized in Table 1.
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Table 1. ASD & preclinical studies. From left to right: Study ID, animals’ strain, age at the time of behavioral/physiological assessment, sex analyzed, the xenobiotic agent used, dose,
age of exposure, route of exposure, exposure measures of control, behavioral tests, physiological measures, and quality of the study.
Study, Year (Reference) Strain/Age at Evaluation/Sex ExposureAgent/Dose/Age/Route Exposure Control Behavioral Tests Behavioral/Pharmacological/Physiological Outcomes Quality Index
Organophosphate compounds




= sociability and reaction to social novelty. ↓maternal care. ↓
anxiety in mums. ↓maternal aggressive behavior. ↑maternal
social investigation. ↓motricity
H
Lan et al. [37] Mice/PND5 (maternal care)and PND90 (sociability)/M
CPF. 2.5–5 mg/kg/day





↓ Sociability. = maternal care. ↓ preference social conditioned
place. = NOR H
Lan et al. [38] Mice/PND90/Both CPF. 2.5–5 mg/kg/dayGD12-15 Gavage N.A.
Three-chambers test. Social
conditioned place preference.
↓ Social preference males vs. the rest (5mg/kg). ↓ Social
preference females vs. males (2.5 mg/kg). = Oxytocin mRNA
levels at hypothalamus
H






Altered maternal behavior in CPF exposed mums (increased
wall rearing and decreased digging). ↓ USVs (calls/min and
duration) only in PND10. ↓ pivoting. ↑ immobility.
MH





↓Maternal aggressive behavior. ↑ Anxiety (Females). =
Depressive-like behaviors. Serotonergic hyposensitivity
(challenged with fluvoxamine)
MH
De Felice et al. [34] Mice/>PND70/Both CPF. 6 mg/kg/dayGD14-17 Gavage
Pups, sex ratio,
weight Social Discrimination test ↑ Social investigation (Females). = Reaction to social novelty MH
Venerosi et al. [33] Mice/>PND70/Both CPF. 6 mg/kg/dayGD15-PND14 Diet
AChE activity, weight,
litter size, sex ratio
Social Recognition test.
Open field
↑ Social investigation males (all phases) and females (second
exposure to the same partner). ↓ reaction to social novelty
(females). ↑ Estrogen Receptor β at Hypothalamus (Males). ↓
Oxytocin at Amygdala (males). ↑ Vasopressin receptor 1a at
amygdala. = locomotor activity
MH
De Felice et al. [35]
BTBR Mice/PND4, 6, 8, 8







USVs. Social Interaction test
↑ (trend) calls. ↑ USVs and social investigation (sniffing)
(males to females). Altered developmental neuromotor
functioning in exposed mice
MH
De Felice et al. [36] Mice BTBR/PND1-21/Both CPF. 6 mg/kg/dayGD14-17 Gavage Weight, litter size Enzyme immunoassay
↑ 15-F2t-IsoP in BTBR model (vs. wild-type). CPF both
reduced (wild-type) and increased (BTBR) 15-F2t-IsoP brain
levels in PND1. CPF 15-F2t-IsoP in BTBR animals (males) at
PND21. CPF increased PGE2 brain levels in BTBR animals at
PND21 (males) and PND70.
MH




Weight Three chambers test
↑ Sociability in adult exposed (both preweaning exposed and
not) APOE3 mice. ↓ reaction to social novelty in APOE3 mice
postnatally exposed to CPF. Adult exposure blocked this
effect. ↑ reaction to social novelty in APOE4 mice postnatally
exposed. Hypothalamus: ↑ Oxytocin mRNA in adult exposed
APOE3, ↓ in adult exposed APOE4. Adult exposure increased
low expression rates of Vasopressin in APOE3. Adult
exposure decreased Vasopressin and vasopressin receptor 1a
mRNA levels in APOE4. Adult exposure decreased Estrogen
receptor 1, Proopiomelacortina in APOE4, amongst others.
MH





GD13-Delivery Pump AChE activity
USVs. Three-chambers test.
Open field. MBT
↑ USVs number in exposed +/−Reeler (males) from its vehicle.
↓ USVs number exposed +/+Reeler (males) from its vehicle. ↓
USVs number in exposed females (both genotypes). ↓ USVs
duration. ↑ social interaction (sniffing, females, both exposed
+/+ and +/−)
ML
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Table 1. Cont.
Study, Year (Reference) Strain/Age at Evaluation/Sex ExposureAgent/Dose/Age/Route Exposure Control Behavioral Tests Behavioral/Pharmacological/Physiological Outcomes Quality Index
Hazarika et al. [42] Rats/adulthood/Both PMD. 35 ppm for 30-, 45- and60-days Adulthood Diet Weight
Social Interaction test.
Open field
= Sociability. ↑ Locomotion (longer exposure protocol).
Multiple histopathological disruptions following the different
exposure protocols.
ML
Ouardi et al. [41] Mice/PND21/Both MAL. 5–15 mg/kg/dayGD6-PND21 Gavage Weight, AChE activity 3-Chambers test. Open field.
↓ Sociability. ↓ Reaction to social novelty. ↑ anxiety (time in
periphery, the highest dose). ↑ Brain MDA (PND21). ↓ brain
CAT and SOD (PND5-21 for the high exposure, PND21 for the
low exposure condition). ↓ brain GST (PND21) and
GPX (PND15)
ML
Other families of pesticides












↓ USVs in exposed mice (highest dose). ↓ Sociability in the
three-chambers test (highest dose). ↓ social interaction with
females. = anxiety. ↑ relative gene expression of brain
phosphatase and Pten (lowest dose). ↓ relative gene
expression of brain phosphatase and Pten and Peg3 genes
(highest dose).
MH
Laugeray et al. [45]
Mice/PND1-15 (USVs).
>PND90 (sociability)/Both
(pups) and M (adulthood)








Maternal behavior. Open field.
Plus-maze
↓Maternal behavior (highest dose). ↓ Sociability (lowest
dose). = reaction to social novelty (lowest dose). ↓
self-grooming (lowest dose). = USVs. ↑motricity (velocity in
the highest exposed mice). = anxiety (lowest dose).
Dysregulation of multiple genes
MH
Dong et al. [44] Mice/PNW6-10/Both
GLA.12 ug/mL For 8 weeks







↓ Locomotor activity. ↓ Social interaction, sociability,
and reaction to social novelty. ↑ compulsivity/anxiety (MBT).
↓ Relative expression of cortical Nrxn1 gene. ↑ Relative
abundance of Bacteroidetes bacteria in the gut. ↓ Relative
abundance of Firmicutes in the gut. ↓ species diversity in the
gut. Gut dysbiosis concerning multiple bacteria at genus level.
↓ Fatty acids biosynthesis.
MH
GD = Gestational day. PND, PNW & PNM = Postnatal day/week/month. s.c. = subcutaneous. F = Female. M = Male. USVs = Ultrasound vocalizations. CPF = Chlorpyrifos. CPO = Chlorpyrifos-Oxon. d = Day.
PMD = Phosphomedon. MAL = Malathion. GLA = Glufosinate ammonium. CYP = Pyrethroid Cypermethrin. N.A. = Not applied. AChE = Acetylcholinesterase. NOR = Novel object recognition. MBT = Marble
Burying Test. = No effects concerning exposure. ↑ Increased following exposure. ↓ Decreased following exposure. 15-F2t-IsoP = 15-F2t-isoprostane. PGE2 = Prostaglandin E2. APOE = Human Apolipoprotein.
MDA = Malondialdehyde. CAT = Catalase. SOD = Superoxide dismutase. GST = Glutathione transferase. GPX = Glutathione peroxidase. Pten = Phosphatase and tensin homolog. Peg3 = Paternally expressed
gene 3. H = High quality. MH = Medium-high quality. ML = Medium-low quality.
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3.3.1. Organophosphates Compounds
There were no preclinical studies labeled as VL or L-quality. Three out of the 13 OP
studies were labeled as ML (23%) [39,41,42], seven were labeled as MH (54%) [31–36,40]
and only three studies were classified as H-quality (23%) [30,37,38]. The OP studies were
characterized as following a gestational exposure protocol (eight out of 13, 62%), although
some studies used postnatal (2 out of 13, 15%) [30,40] and continuous gestational-postnatal
exposure protocols (two out of 13, 15%) [33,41], with the exception of the adult study.
Four of these studies used different genetic models of autism such as BTBR mice [35,36]
and KO reeler mice [39] and other genes that could potentially modulate social behavior
such as the different polymorphism of the human Apolipoprotein E (APOE) [40].
Gestational exposure to OPs both decreased [31,37,38] and enhanced [32,34,35] dif-
ferent social and communicative behaviors in mice. Lan et al. [37] exposed male mice
from GD12 to 15 using a dose ranging from 2.5 to 5 mg/kg/day and found decreased
social interaction and altered preference in a socially conditioned paradigm, without ma-
ternal care alterations. This result was confirmed in a later study [38] in both exposed
males (highest dose) and females (lowest dose), without observing significant effects of
the exposure on hypothalamic oxytocin mRNA expression. Further, Venerosi et al. [31]
found that these abnormal social interaction patterns were complemented by alterations in
communication skills, observing a decrease in the number and duration of the exposed
pups’ ultrasonic vocalizations (USVs) as well as alterations in maternal behavior (increased
licking and exploration-tendency) following 6 mg/kg of CPF from GD15 to 18. Venerosi
et al. [32] found a decrease in maternal aggressive behavior, increased anxiety in females,
and a generally hyposensitized serotonergic system. De Felice et al. [34] exposed their
mice following a similar exposure protocol and found that the exposed females showed
enhanced social investigation rates. Further, De Felice et al. [35] also found an increased
rate of USVs and social investigation in males using the same exposure protocol in BTBR
mice. In addition to their previous observations, De Felice et al. [36] found that the BTBR
mice had, at baseline, higher levels of two of the most significant biomarkers of oxidative
stress, 15-F2t-IsoP, and PGE2, both of which are associated with ASD. Interestingly, these
authors found that this gestational exposure to CPF generally increased the levels of these
molecules, eminently in male BTBR mice, which is congruent with their previous find-
ings of altered neuromotor development in BTBR exposed animals [35]. Finally, Mullen
et al. [39] used heterozygous/homozygous reeler mice (Rl+/− and Rl+/+, respectively) and
exposed them to CPO (6 mg/kg/day) from GD13 to delivery. The authors found that the
exposure increased the number of USVs in the +/− male mice, but the opposite was found
in the +/+ condition, whilst the females decreased USVs showed increased levels of social
interaction in both genetic conditions.
Postnatal exposure to OPs was analyzed in Venerosi et al. [30] and Basaure et al. [40],
both studies using CPF at the preweaning developmental stage. Venerosi et al. [30] found
that 3 mg/kg from PND11 to 14 had no effects on the sociability indexes of mice but
altered maternal care and social investigation whilst also reducing maternal aggression,
a finding that was presumably related to a decreased state of anxiety in the exposed female
rats. Further, Basaure et al. [40] used human APOE-3 or 4 mice models to characterize the
presumable influences of genetic background on the social mismatches associated with
preweaning CPF exposure (1 mg/kg/day from PND10 to 15). They also repeated this
exposure during adulthood in both postnatal exposed and non-exposed groups. Postnatal
CPF exposure increased the reaction to social novelty in APOE4 mice but reduced this
reaction in APOE3 mice, this latter effect being blocked following the adult exposure
protocol. The authors found that the adult exposure regime enhanced sociability regardless
of the prior exposure condition in the APOE3 mice. Furthermore, the authors also analyzed
various molecular markers and found that adult CPF exposure differentially modulated the
hypothalamic levels of Oxytocin and Vasopressin mRNA (amongst others) depending on
genotype background. Interestingly, chronic exposure (30, 45, or 60 days) to PMD (35 ppm)
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during adult ages did not alter sociability but produced a significant increase in locomotor
activity along with multiple histological alterations in rats [42].
Finally, the studies that employed continuous gestational-postnatal exposure were
those of Venerosi et al. [33] and Ouardi et al. [41], which used CPF and MAL, respectively.
Venerosi et al. [33] exposed mice to 6 mg/kg of CPF from GD15 to PND14 and found a
generalized enhancement in social investigation/recognition in both sexes (stronger in
males) without altering motricity. Interestingly, the authors also analyzed the levels of
oxytocin and vasopressin1a receptor in the amygdala and found that CPF exposure reduced
the former in males and increased the latter. Ouardi et al. [41] exposed their mice to MAL
(5–15 mg/kg) from GD6 to PND21 and found a significant reduction in sociability and
reaction to social novelty in the exposed animals compared with their control counterparts,
along with an increased anxiety state and multiple molecular alterations in the CNS such
as increased MDA levels and decreased CAT, SOD, GST and GNX in a dose and age-
dependent fashion, presumably indicating an increased state of cellular oxidative stress in
exposed rodents.
3.3.2. Other Potential Neurotoxic Compounds
All three studies that used xenobiotic compounds other than OPs were labeled as MH-
quality [43–45]. Dong et al. [44] exposed female mice to GLA from 8 weeks before mating
to delivery, whilst Laugeray et al. 43], and Laugeray et al. [45] used GLA (the former) and
CYP (the latter) in a continuous gestational-postnatal exposure protocol in mice models.
Dong et al. [44] exposed mice to 12 µg/mL of GLA (in water) and found a general decrease
in social interaction and reaction to social novelty, along with decreased locomotor activity,
increased compulsive/anxiety-like behavior, and a reduction in the mRNA expression
levels of the cortical Nrxn1 gene. The authors also found a significant gut dysbiosis
characterized by an increase and decrease of both Bacteroidetes and Firmicutes bacteria at
the phylum taxa level and reduced biosynthesis of fatty acids, amongst other molecular
changes. These effects on sociability were also found in Laugeray et al. [43], who exposed
rodents to GLA from early gestational ages to PND14 in a range of doses from 0.2 to
1 mg/kg/day, finding a significant decrease in USVs and social interaction rates following
the highest dose (without affecting anxiety-state levels), along with several molecular
outcomes such as a reduction in both Pten and Peg3 brain genes, which are commonly
associated with ASD. Similarly, Laugeray et al. [45] also found decreased sociability and
self-grooming and increased motricity in mice exposed to 5 mg/kg/day of CYP, as well
as altered maternal behaviors following a higher dosage (20 mg/kg/day), without effects
on USVs and anxiety. Interestingly, the authors also found that these exposure regimens
altered multiple genes.
3.4. Pesticide Exposure, Cognitive and Behavioral Alteration Related to ASD: Clinical Studies
The clinical studies included in this review evaluated different aspects related to
neurodevelopmental, behavioral, and cognitive outcomes. This broad spectrum of study
designs, methods, and functions evaluated added certain difficulties since each study
assessed different aspects at different ages, thus hindering the possibility of drawing
firm conclusions.
The 45 human studies included in this review are summarized in Table 2 according to
the quality index. We have further categorized these studies by describing them according
to the type of pesticide and period of exposure.
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Table 2. ASD & clinical studies. From the left to the right: Study ID, Study design/region, age at evaluation/sex/sample size, type, agent and source of exposure assessment,




















Prenatal (prior to delivery) and
postnatal (3 yo) urine samples
Gesell Developmental
Schedules
No relationship between prenatal TCPy exposure and
neurodevelopment alterations. ↓Motor and social
development related to postnatal exposure mainly
in boys
VH









No association between prenatal or postnatal exposure
was found in children at 1 yo. Prenatal exposure to DEs
and DAPs was associated with a ↓ in social scores
(among boys), while postnatal exposure to DMs and
DAPs ↑ adaptive domain in children 2 yo
VH








↓ Overall neurodevelopment scores after prenatal
exposure to OP measured by urine DAPs metabolites.
DAPs concentrations, specially DEs was associated with
lower scores on the behavior scale and DMs was
associated with poorer scores in a passive tone, active
tone, and primary reflex
VH




Prenatal (13 and 26 gw) and
postnatal (6 mo, 1, 2, 3.5, 5 yo)
urine samples
Wechsler Intelligence Scale for
Children—4th edition
Prenatal DAPs exposure was associated with lower
cognitive scores, especially, in IQ, verbal comprehension
(DAPs), and processing speed (DEs). Postnatal urinary
DAPs concentrations were not associated with
cognitive scores
VH
Donauer et al. [51] HOME Cohort/Ohio (USA)
Annually from 1 to
5 yo/Both/N = 327
Env; OP (DAPs)
Prenatal urine samples (16 and
26 gw)






and Primary Scale of
Intelligence—3rd edition
No effect on cognitive and
neurodevelopmental performance VH




1, 2, and 6-9 yo Both/N = 169
Env; OP (DAPs)
Maternal blood, cord blood,
and prenatal urine samples
(between 26 and 28 gw)








↓mental development by DAPs (1 and 2 yo) and DMs
(1 yo, race/ethnicity). No association in DAPs and
psychomotor development. DEs negatively associated
with IQ, perceptual reasoning, and working memory in
children 7–9 yo
VH




Prenatal urine samples (during
pregnancy)
Bayley Scales of Infants
Development—2nd edition
Maternal DAPs were negatively associated with
cognitive and mental abilities as well as with
PON1 polymorphism
VH
Kongtip et al. [56] Cohort/Thailand 5 moBoth/N = 50
B; OP (DAPs)
Prenatal urine samples (around
28 gw)
Bayley Scales of Infants
Development—3rd edition
DEs exposure during 3rd trimester were associated with
↓ in cognitive and motor function, while DAPs maternal
levels only affected motor scores
VH




Prenatal (prior to delivery) and
postnatal (2 yo) urine samples
Gesell Developmental
Schedules
Prenatal DEs exposure is associated with ↑ risk of being
developmentally delayed (in boys). Postnatal DAPs and
DEs exposure showed delays in development, especially
in motor and social area among boys
VH





















(between 13 and 19 gw)
Social Responsiveness Scales
DAPs exposure was not associated with autism
symptoms after adjusting for covariates. No evidence
that PON1 polymorphism modified prenatal DAPs
exposure and autism risk/ASD
VH
Sagiv et al. [59] CHAMACOS Cohort/California (USA)





(13 and 26 wo)
Social Responsiveness
Scales/Behavioral Assessment





Maternal DAPs were associated with an ↑ in
autism-related traits in childhood and adolescence.
However, no association was observed on facial









Prenatal (early, mid-, and late
pregnancy) and postnatal (6 yo)
urine samples
Social Responsiveness Scales No association between DAPs and autismsymptomatology/Autistic traits VH











OP exposure assessed by DMTP metabolite
concentrations tended to ↑ the risk of autism only in girls.
No association were observed without
sex-stratification/ASD
H










DEs levels were associated with poorer social
responsiveness in black participants with a stronger











(between 6 and 11 yo)
Wechsler Intelligence Scale for
Children—4th edition
DAPs levels associated with a ↓ in verbal comprehension,
processing speed, and IQ among boys H
Silver et al. [60] Chinese Cohort/Fuyang (China)
6 wo and 9 mo
Both/N = 199
Env; OP
Prenatal cord blood samples
Peabody Development
Motor Scales
No significant findings were observed at 6 wo. Naled
and CPF exposure associated with deficits in motor
function, among girls at 9 mo
H
Woskie et al. [62] Cohort/Thailand Between 0 and 4 doBoth/N = 82
B; OP (DAPs)
Prenatal urine samples (7 gm
and prior to delivery)
Brazelton Neonatal Behavioral
Assessment Scale
↑ Score in the Range of state cluster score associated with
maternal DEP metabolite levels and ↑ urinary DMP














Scale/Bayley Scales of Infant
Development
No effects on reflex, neurological or psychomotor
development at 1 mo VH
Brown et al. [64] FiPS-A Case-Control/Finland 0–7 yo/BothN = 1,556
Env; OC
Prenatal blood samples (each
trimester)
Autism Diagnostic
Interview—Revised DDE ↑ odds of autism/ASD VH







Prenatal blood (pregnancy) and
breast milk (30 days after
delivery) samples
Bayley Scales of Infant
Development—2nd edition No specific results related to OC pesticides exposure VH




















Placenta samples (at delivery)
McCarthy Scales of
Children’s Abilities
↓ Cognitive performance, especially, working memory
and quantitative area (numerical memory, counting,
and sorting). No effects were observed in
perceptual-performance, verbal, and motor areas
VH
Boucher et al. [73] Timoun Cohort/Guadeloupe 18 moBoth/N = 204
Env; OC (Chlordecone)






Prenatal exposure was associated with poorer motor
ability among boys
Postnatal exposure: no significant association with
personal-social, communication, problem-solving,
fine and gross motor scores
VH
Braun et al. [66] HOME Cohort/Ohio (USA)
4 and 5 yo
Both/N = 175
Env; OC
Prenatal and blood samples
(2nd trimester and at delivery)
Social Responsiveness Scales Maternal trans-nonachlor ↑ autistic behaviors/ASD VH




Adapted versions of the
MacArthur Communicative
Development Inventory
No association between β-HCH or DDE and
communication scores (15 and 38 mo). HCB ↓ vocabulary
comprehension and production (15 mo) and ↓
intelligibility scores (38 mo). DDT was associated with a
↓ in communication scores (38 mo)
VH









No association between pesticides exposure and odds of
autism/ASD VH
Torres-Sanchez








DDE exposure during the 3rd trimester was associated
with ↓ cognition, verbal comprehension, and memory VH
Kao et al. [68] FiPS-A Cohort/Taiwan 8–12 moBoth/N = 55
Env; 20 OC
Postnatal breast milk (between
2 wo and 1 mo) samples
Bayley Scales of Infant
Development—3rd edition
DDT and trans-chlordane ↓ cognitive, language,
social-emotional, and motor scores H










No clear evidence that higher levels of prenatal exposure








Prenatal (6–19 gw) and
postnatal (6 yo) urine samples
Wechsler Intelligence Scale for
Children—4th edition
No effect on neurocognitive scores after prenatal
exposure
↓ Verbal comprehension and working memory associated
with postnatal exposure to 3-PBA and cis-DBCA
VH




Prenatal (6–19 gw) and
postnatal (6 yo) urine samples
Strengths and Difficulties
Questionnaire
No significant association between maternal urinary PT
metabolites and child neurobehavioral deficits.
Childhood urinary levels of 3-PBA and trans-DCCA
associated with ↑ odds of behavioral disorders
VH




1, 2, 4, 6, 7–9 yo
Both/N = 162
Env; PT






3-PBA associated with depression, somatization,
behavioral and emotional deficits. Cis-DCCA exposure
was associated with behavioral regulation, emotional and
externalizing problems, while, trans-DCCA was not
associated with adverse effects
VH
Horton et al. [77] CCEH Cohort/New York (USA)
3 yo
Both/N = 342
Env; PT (PBO and Permethrin)
Prenatal air (3rd trimester),
maternal or cord blood
(delivery) samples
Bayley Scales of Infant
Development—2nd edition
No association between permethrin air and blood
samples with mental or motor development. ↓ in mental
development after prenatal PBO exposure, while no
association was found in motor development
VH




















Bayley Scales for Infant
Development—Spanish
version, 2nd edition
Lower mental development in 1 yo children, being
stronger in girls. No association between maternal 3-PBA
and motor development at 2 or 3 years of age
H
Carbamates compounds




Prenatal (prior to delivery) and
postnatal (3 yo) urine samples
Gesell Developmental
Schedules
Prenatal exposure associated with ↓ in social and
adaptative behaviors Postnatal exposure associated with
language and social behavior deficits
VH
Mora et al. [80] ISA Cohort/Matina (Costa Rica)
Pregnancy and 1 yo
Both/N = 355
B; CM (Mancozeb)
Hair, blood, and prenatal urine
samples (19, 30, and 33 gw)
Bayley Scales of Infants
Development—3rd edition
↓ Cognitive abilities in girls, while language and fine
motor development were affected in boys. ↓
social-emotional scores in both sexes
VH
Neonicotinoids compounds
Keil et al. [81] CHARGECase-control/California (USA)














Association between autism and Imidacloprid
exposure/ASD VH
Mixture: pesticides and other potential neurotoxic
Andersen et al. [82] Cohort/Denmark
Between 6 and 11 yo
Both/N = 177
Oc; Insecticides, fungicides,









Intelligence Tests of Cognitive
Abilities/Copying Test of the
Stanford—Binet, 4th edition
↑ Brainstem evoked potential (BAEP) latency (boys and
girls). Impairment in neurobehavioral, language, motor
speed, and short-term memory functions, only in girls
VH
Gunier et al. [91] CHAMACOS Cohort/California (USA)
7 yo
Both/N = 283
Env; 15 OP, 6 CM,
2 Mn-fungicide, 8 PT, and 1 NN
Prenatal house-dust samples
Wechsler Intelligence Scale of
Children—4th edition
OP is associated with IQ and verbal comprehension
deficits. OP and CM are associated with ↓ IQ. NN, PT,
and Mn-fungicides are associated with ↓ in IQ,
perceptual reasoning, and verbal comprehension
VH
Schmidt et al. [89] CHARGECase-Control/California (USA)
2 and 5 yo
Both/N = 516
B; OP, PT, and CM









Exposure to OP, PT, and CM ↑ autism risk, while FA
intake ↓ the risk/ASD VH
Eskenazi et al. [84] VHEMBRE Cohort/Limpopo(South Africa)
1–2 yo
Both/N = 705
B; OC and PT
Blood and urine (prior and
post-delivery) samples
Bayley Scale of Infant
Development—3rd edition
(1 yo) No effect of DDT/DDE exposure and
neurodevelopment. Cis-DCCA, trans-DCC,A, and 3-PBA
were associated with socio-emotional deficits. (2 yo)
Motor problems associated with DDT, while DDE ↓ in
communication and language. Cis-DBCA were
associated with a ↓ in communication and language,
among girls (1 yo) and both sexes (2 yo)
VH




















1, 2, 4–7, 9 yo
Both/N = 404
Env; OP and PT
Prenatal (between 25 and










DMs levels were associated with worse internalizing
scores (anxiety scale) and ↑ working memory among
black children, while DEs was associated with worse
working memory scores. No association was observed
with PON1 polymorphism
VH
McCanlies et al. [87] CHARGECase-control/California (USA)












No association between pesticides and autism/ASD VH
Ostrea et al. [88] Cohort/Bulacan (Philippines)
2 yo
Both/N = 754
B; CM (Propoxur) and PT
Prenatal maternal blood,
hair and postnatal cord blood
and children hair
Griffiths Test
Motor development was affected after Propoxur
exposure among boys
No association was observed between Propoxur
exposure and social behavior
VH
Shelton et al. [90] CHARGECase-Control/California (USA)
Between 2 and 5 yo
Both/N = 970
B; OP, CM, PT, and OC









↑ autism risk after prenatal OP pesticides (1st and 2nd










Prenatal (3 mo before
conception and during
pregnancy) and postnatal (first




↑ autism risk after prenatal exposure to pesticides such as
Glyphosate, CPF, MAL, Diazinon, Avermectin,
and Permethrin/ASD
VH
Gw = gestational week. gm, mo = gestational/month old. yo = year old. Oc = occupational. Env = environmental. B = both. DAP = dialkyl phosphate. DM = dimethylphosphate. DE = diethyl phosphate.
DMTP = dimethylthiophosphate. DDT = dichlorodiphenyltrichloroethylene. DEP = diethylphosphate. TCPy = 3,5,6-trichloro-2-pyridinol. DDE = dichlorodiphenyldichloroethylene. PON1 = paraxonase 1.
DCCA = 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid. DBCA = cis-3-(2,2-dibromovinyl)-2,2-DCCA. 3-PBA = 3-phenoxybenzoic acid. PBO = piperonyl buroxide. HCH = hexachlorocyclohexane.
HCB = hexachlorobenzene. Mn = manganese fungicides. IQ = intelligence quotient. FA = folic acid. CPF = Chlorpyrifos. MAL = Malathion. VH = Very high. H = High quality. MH = Medium-high quality. ML =
Medium-low quality.
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3.4.1. Organophosphate Compounds
We found 17 studies (37.8%) that referred to the association between OP and autism or
developmental disorders. Of these, 12 were classified as VH (70.6%) [46,48–53,56–59,61], four as
H (23.5%) [47,54,55,60] and only one [62] was classified as MH-quality. Twelve studies out
of 17 assessed only prenatal exposure to OP, whilst five out of 17 (29.4%) [46,48,50,57,61]
evaluated both prenatal and postnatal exposure and only Gonzalez-Alzaga et al. [55]
studied postnatal exposure alone.
All of these studies assessed prenatal exposure to OPs by means of maternal urine
or cord blood biomarkers, or child urine biomarkers (in the case of postnatal exposure).
In general, the studies analyzed a set of different dialkyl phosphate metabolites (DAP)
including dimethyl (DM) phosphate and diethyl (DE) phosphate metabolite [47–54,56–62].
Only two studies used other metabolites such as 3,5,6-trichloro-2-pyridinol (TCPy) as an
indicator of exposure to CPF [46] or a direct estimation of pesticide exposure together with
metabolites [60].
Two of these studies, conducted in Thailand and China, evaluated the effects of prena-
tal exposure to OPs during the first postnatal week [49,62]. In a pilot study, Woskie et al. [62]
found a significant positive relationship between maternal urinary DM phosphate metabo-
lites levels and the Bazelton Neonatal Behavioral Assessment (NBAS) habituation cluster
score, along with a significant positive relationship between total DE phosphate metabolites
and the NBAS range of state cluster score. However, Zhang and coworkers [49] reported a
consistent negative association between neurodevelopmental scores and OPs metabolites
in maternal urine, that is, they found an association between DEs and lower scores on the
behavior scale whilst DMs concentrations were associated with poorer scores in passive
tone, active tone, and primary reflex [49].
Another two studies evaluated children during the first year of life, between 6 weeks
and 9 months of age [60] and at 5 months of age [56]. The former study measured metabo-
lites and pesticides in cord blood samples from a Chinese population, and whilst they
found no effects in six-week-old children, a significant negative association was found
between exposure to Naled and CPF and motor function among girls aged nine months [60].
Moreover, Kongtip and coworkers [56] studied a population from Thailand and found an
association between concentration of DEs in maternal urine during the third trimester of
gestation and a decrease in cognitive and motor function at 5 months of age, as well as a
significant relationship between prenatal total DAP levels and motor scores.
In addition, three studies evaluated children aged from one to two years [48] and at
two years of age [53,57]. Wang and coworkers [48], studying a population from China,
found a significant negative association between prenatal urine levels of DEs and DAPs and
social scores (among boys) at two years of age. In addition, in this study, postnatal urine
levels of DAPs and DMs were also associated with increased scores on the adaptive domain
in children at two years of age [48]. A study conducted in California, with the CHAMA-
COS cohort, found that maternal DAPs were negatively associated with cognitive and
mental abilities as well as with child PON1 polymorphism, whilst no sex differences were
reported [53]. Moreover, in a study of a cohort living in Shenyang (China), Liu et al. [57]
reported that prenatal DEs levels were associated with an increased risk of developmental
delay (in boys), while postnatal DAPs and DEs levels were associated with delays in
development, particularly in motor and social areas among boys [57].
Two more studies evaluated children at three years of age [46,47] with the former
finding no association between prenatal maternal levels of TCPy metabolite, although the
authors reported an association between postnatal levels of the metabolite TCPy and social
development, mainly in boys. Philippat et al. [47], evaluated a population of mothers from
California at high risk of having a child with autism (the MARBLES cohort) and found
a positive association between exposure to OPs and risk of autism (clinical diagnostic),
but only in girls. However, it is necessary to interpret these results with caution since the
sample size for girls was very small.
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Moreover, a set of four studies longitudinally evaluated outcomes in children aged
from one to five years [51], from one to nine years [52,54], and from one to fourteen years
of age [59]. Donauer and coworkers [51] did not find any effect at any age on cognition
and neurodevelopment in a population from Ohio. However, in another study conducted
in a cohort from New York (80% black or Hispanic women) where metabolites of OPs
were measured in cord blood samples, the levels of DAPs were negatively associated with
mental development at one and two years of age but no association was observed between
DAPs and psychomotor development. In this study, certain associations were also found
in relation to DAPs and race/ethnicity at one year of age. In this cohort, prenatal levels
of DEs were negatively associated with IQ, perceptual reasoning, and working memory
in children from seven to nine years, associations that are influenced by PON1 Q192R
QQ genotype, which affects CPF metabolism [52]. In a similar vein, and in the same
cohort from New York, Furlong et al. [54] found that levels of DEs were associated with
poorer social responsiveness in black participants, with a stronger effect found in boys,
although in this study only social functioning was evaluated in children from seven to nine
years [54]. Similarly, in a study conducted in California (CHAMACOS), maternal DAPs
were associated with an increase in autism-related traits in childhood and adolescence,
but no association was observed with deficits on specific facial recognition tests for children
aged nine and twelve years [59].
Evaluations conducted with prenatally exposed cohorts aged six [61], seven [50],
and eight years [58] reported different outcomes. A study conducted in a cohort from the
Netherlands found no association between DAPs measured in urine during pregnancy and
autism traits [61]. In a Californian cohort (CHAMACOS), prenatal exposure to DAPs was
associated with lower cognitive scores, particularly in IQ, verbal comprehension (DAPs),
and processing speed (DEs). However, postnatal urinary concentrations of DAPs were not
associated with cognitive scores, and in this study, autism traits were not evaluated [50].
In the HOME cohort from Ohio, levels of DAPs were not associated with autism symptoms
and no evidence was found to suggest that PON1 polymorphism modified prenatal DAPs
exposure or autism risk [58].
Only one study evaluated postnatal exposure, in a cohort of children between the age
of six and eleven years from Andalusia (Spain) [55]. In this study, the authors reported that
urine DAPs levels of the children were associated with a decrease in verbal comprehension,
processing speed, and IQ (primarily in boys). Information about prenatal exposure and
the postnatal period until evaluation was estimated according to the proximity of their
residence to agricultural areas, with the authors concluding that postnatal exposure to
pesticides can negatively affect children’s neuropsychological performance while prenatal
exposure was weakly associated with neurodevelopment impairment.
3.4.2. Organochloride Compounds
Only 11 out of 45 studies carried out in humans reported an association between
OC pesticides and autism. Of these, nine were classified as VH (81.8%, [63–71]), and
Kao et al. [68] and Lyall et al. [69] were classified as H-quality. Prenatal exposure was the
most frequently studied exposure for OC, except Kao et al. [68] who studied postnatal
exposure, while prenatal and postnatal exposure was reported by Kim et al. [65] and
Boucher et al. [73].
As previously stated, we evaluated studies of prenatal exposure that measure OCs
metabolites in maternal blood during pregnancy, along with breast milk samples of children
given postnatal exposure. The literature focuses on DDT and one of its principal break-
down products DDE. Authors that studied the effects of this exposure also assessed other
metabolites such as hexachlorocyclohexane (HCH) and hexachlorobenzene (HCB) [63–71].
Only two studies assessed other OC compounds (Mirex, [72] and Chlordecone, [73]).
Two studies evaluated children during the first year of life [63,64]. Although no effects
were found on reflexes, neurological or psychomotor development after prenatal OC
exposure at one month of age [63], a national birth cohort study (Finland) which evaluated
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children within the age range at risk of ASD (between 0 and 7 years of age) found a link
between DDE exposure and an increased likelihood of developing autism [64].
Only one study assessed children’s developmental problems at 18 months of age [73].
Prenatal Chlordecone exposure was measured from umbilical cord blood, whereas post-
natal exposure was measured from breast milk collected at 3 months postpartum. Nev-
ertheless, boys prenatally exposed to this OC compound showed poorer motor abilities,
whilst no significant association was found between childhood exposure and personal-
social, communication, problem-solving, fine and gross motor development [73]. A further
evaluation was conducted in children at 4 years of age [72]. While no effects were observed
on perceptual-performance, verbal, and motor areas, the INMA cohort showed deficits in
cognition, particularly in working memory and quantitative areas (numerical memory or
counting and sorting) [72].
Further, four studies evaluated the outcomes in children during the first five years of
life, that is, from 13 to 24 months [65], 15 to 38 months [67], 42 to 60 months [71], and four
to five years [66]. Even though analysis of maternal OC serum levels did not reveal any
specific outcome [65], Jeddy and coworkers [67] reported that an increase of HCB levels
was associated with vocabulary comprehension and production deficits in 15-month-old
children, while a decrease in intelligibility scores were observed at 38 months of age.
The same study found communication problems associated with maternal DDT levels in
children aged 38-months-old, but no association was observed between β-HCH or DDE
and communication scores in both exposure periods [67]. In addition, a study conducted
in Morelos (Mexico) found that DDE exposure during the third trimester of pregnancy was
associated with verbal comprehension, cognitive and memory problems [71], while the
HOME cohort showed a link between trans-nonachlor and an increased risk of developing
autism behaviors [66].
Two more studies evaluated children aged between three and 10 years [69] and from
four to 9 years [70]. All of these works evaluated the EMA population based on a case-
control study that identified biomarkers and their possible association with the risk of
developing autism. Lyall and coworkers [69] found no clear evidence that higher levels
of DDE and trans-nonachlor in maternal serum analyzed during the second trimester of
pregnancy increased the risk of the disorder, whilst Hamra et al. [70] found no association
between OC exposure and the risk of developing autism.
Postnatal exposure to OC metabolites (measured from breast milk) was only assessed
in one study [68] in children aged between 8 and 12 months, finding that exposure to DDT
and trans-nonachlor were associated with socio-emotional, language, and cognitive deficits,
along with motor problems.
3.4.3. Pyrethroid Compounds
With regard to PT, five out of 45 (11.1%) studies were included. Of these, four were
classified as VH (80.0%, [74–77]) and only Watkins et al. [78] was classified as H-quality.
All studies assessed prenatal exposure, except for Viel et al. [75,76] who evaluated prenatal
and postnatal PT exposure.
The effects of PT exposure were generally assessed by measuring metabolites in
maternal urine, cord blood or air samples, and/or child urine. All of these studies
assessed PT differently, by 3-phenoxybenzoic acid (3-PBA) (a non-specific metabolite),
Permethrin, Cypermethrin and Cyfluthrin (by their cis or trans-3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropane carboxylic acid (cis or trans-DCCA) metabolite), 4-Fluoro-3-PBA (4-
F-3-PBA) (as a specific metabolite of cyfluthrin) and cis-3-(2,2-dibromovinyl)-2,2-DCCA (cis-
DBCA) (as a deltamethrin specific metabolite) [74–76,78]. The only exception was the study
by Horton et al. [77], which assessed Permethrin and Piperonyl butoxide (PBO) exposure.
One study evaluated children at two and three years of age [78], while Horton et al. [77]
only evaluated children at three years of age. A study conducted in Mexico (the ELEMENT
cohort) found lower mental development in 2-year-old children, with stronger effects in
girls. The same study found no association between maternal urine 3-PBA levels and motor
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development at both ages of evaluation [78]. Moreover, studies carried out with a New
York cohort (CCEH) also found mental development deficits with PBO air exposure during
the third trimester of pregnancy (but not motor problems), whereas no association between
Permethrin exposure and mental and motor development were found at two years of
age [77]. Another New York cohort study (Mount Sinai Children’s Environmental Health),
which measured PT metabolites in maternal urine, assessed outcomes in children aged
between one and nine years. The results revealed depression, somatization, behavioral
and emotional deficits after 3-PBA exposure, and while cis-DCCA was associated with
externalizing problems and poorer behavioral and emotional regulation, the trans-DCCA
isomer was not associated with any adverse effects [74].
Finally, whilst no effects were observed following prenatal PT exposure in the PELAGIE
cohort, postnatal 3-PBA and cis-DBCA exposure assessed in urine in 6-year-old children
was associated with deficits in verbal comprehension and working memory [75], whilst an
increased risk of behavioral disorders was also observed following 3-PBA and trans-DCCA
exposure [76].
3.4.4. Mixtures of Pesticides and Other Potential Neurotoxic Agents
The remaining articles, specifically 12 out of 45 (26.7%), studied the effects of exposure
to a common mix of pesticides and other toxicants or several types of pesticides. All of
these studies were classified as VH [46,80–85,87–91]. Eight out of 12 studies assessed only
prenatal exposure, three out of 12 (25.0%, [46,83,88]) assessed both prenatal and postnatal
exposure, whereas only one study [87] evaluated postnatal exposure.
Whilst previous studies evaluated a single exposure to pesticides in children, the most
common situation in humans is that they are exposed to a wide variety of pesticides,
something that is formally taken into account in recent studies related to the concept of
exposome science [92]. In this regard, general exposure to pesticides was assessed in three
out of 12 studies (25.0%, [82,83,87]). Moreover, six out of 12 studies assessed the effects
of exposure to a mix of different pesticides (50.0%, [84,85,88–91]), whilst the remaining
two assessed CM exposure (16.7%, [46,80]), and only Keil et al. [81] assessed NN exposure.
With regard to CM, maternal urine, blood, hair, cord blood, or child urine samples were
used as measures of prenatal and postnatal exposure to Propoxur, Carbofuranphenol,
and Mancozeb [46,80,88]. In addition, prenatal exposure to NN was evaluated by measur-
ing household levels of Imidacloprid [81]. The remainder of the included studies measured
prenatal and/or postnatal exposure to OP, PT, or OC, as mentioned in the previous sections.
Two studies evaluated children during the first two years of life [83,84]. A case-
control study based on individuals with a primary diagnosis of autism disorder reported
an increased risk of ASD following prenatal exposure to pesticides such as CPF, MAL,
diazinon, avermectin, and Permethrin during the first year of life [83]. A study carried
out in Limpopo (South Africa) found no adverse effects on neurodevelopment at one
year of age, whilst DDT exposure was associated with motor problems, and two-year-old
children showed communication and language deficits following DDE exposure. This same
study assessed exposure to PT metabolite, measured by blood and urine. Socio-emotional
problems were observed during the first year of life, while cis-DBCA metabolite exposure
was linked to communication and language deficit in 1-year-old girls and 2-year-old
children of both sexes [84].
Moreover, three studies evaluated outcomes in children aged from 2 to 5 years [87,89,90].
All of these studies evaluated a Californian population (CHARGE cohort), which showed
an increased risk of autism in children following prenatal exposure to OP (during the
second trimester) and PT (3 months before conception and during the third trimester
of pregnancy) [90]. Similarly, Schmidt et al. [89] found the same increased risk of the
disorder following OP, PT, and CM exposure, while folic acid (FA) intake decreased this
risk. However, no association was found between autism and general postnatal exposure
to pesticides [87].
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Two more studies evaluated children from one to nine years of age [85] and six to
11 years [82]. One study assessed the Mount Sinai Children’s Environmental Health
cohort (New York) and found an association between prenatal urine DMP levels and
internalizing problems and better scores in working memory in black children, and whilst
DEP was associated with poorer working memory scores, no association was found with
PON1 polymorphism [85]. A Denmark population, which evaluated general prenatal
pesticide exposure, found an increase in brainstem evoked potential (BAEP) latency in both
sexes, as well as impairments in neurobehavioral, language, motor speed, and short-term
memory functions, but only in girls [82].
Gunier et al. [91] evaluated 7-year-old children using a number of tests. This study
assessed the CHAMACOS cohort, which showed IQ and verbal comprehension deficits
following OP, NN, and PT exposure. Furthermore, exposure to NN and PT was also linked
to perceptual reasoning problems, while combined exposure to OP and CM was only
reported to be associated with IQ deficits [91]. Further, three studies evaluated exposure
to only CM at one year [80], two years [88], and three years of age [79]. During the
first year of life, a decrease in cognitive abilities in girls, deficits in language and fine
motor development in boys, and socio-emotional deficits in both sexes were observed
following prenatal exposure to Mancozeb [80]. Moreover, exposure to Propoxur was also
associated with motor development problems in boys, while no social behavior deficits
were observed [88]. Finally, prenatal urine levels of Carbofuranphenol were linked to a
decrease in social and adaptive behaviors, whereas postnatal exposure was associated with
language and social behavior deficits [79].
Finally, only Keil et al. [81] assessed prenatal NN exposure using measurements
of Imidacloprid in children aged between 3 and 4 years. This study, conducted with a
Californian population (CHARGE cohort), found an association between Imidacloprid and
autism disorder [81].
4. Discussion
4.1. Preclinical Studies and ASD
A total of 16 preclinical studies were finally included in the present systematic review.
All of them studied some effect on communication or social behavior after being prenatally
or postnatally exposed to OP, PT, or GLA.
When dividing the analysis according to developmental stages and compounds, ges-
tational exposure to CPF decreased sociability in mice exposed from GD12-15 to doses
from 2 to 5 mg/kg in the best-qualified studies [37,38]. MH classified studies also revealed
decreased USV rates and maternal behavior when exposure occurred later during gesta-
tion [31,32], but the opposite was also true for both vocalizations and social investigation
in male BTBR mice [35] and social interaction rates in wild-type female mice [34]. How-
ever, this gestational exposure protocol from GD14 to 17 in BTBR ASD-like mice models
was associated with deep alterations in secondary behavioral markers usually observed
in ASD patients such as delayed neuromotor development [35], along with an increase
in various biomarkers of oxidative stress that are typically associated with autism [36].
Interestingly, this phenomenon of enhanced social and communicative traits was also
observed in another model of ASD-like genetic background by using heterozygotes Reeler
mice and exposing them from GD13 to delivery, as found in Mullen et al. [39], a study
categorized as ML quality. This study is of special relevance as the influences of CPO
on social outcomes varied depending on sex, where +/− neonate female mice decreased
USVs number whilst their male counterparts increased them, as well as exposed females
generally enhanced their social interaction during adolescence. These results support the
notion that genetic background and environmental agents interact giving different results
in a sex-dimorphic manner. As CPO exposure altered females’ behavior in both +/− and
+/− conditions, one explanation could be because of the differences that exist between sexes
regarding the development of the cholinergic system during early neurodevelopment [93].
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Studies of postnatal exposure also yielded inconclusive results. The only H-quality
study shows that pre-weaning exposure to CPF altered maternal care and aggressive
behavior but enhanced maternal social investigation without affecting the performance
of pups in the three-chambers test [30]. Interestingly, one MH-quality study found that
pre-weaning exposure to doses as low as 1 mg/kg/day differentially affected the reaction
to social novelty in mice depending on the APOE genotype background, with decreased
(APOE3) and enhanced (APOE4) rates, both regulated by re-exposure to CPF during
adulthood [40]. The earlier data is relevant since isoform 3 is most widely expressed in
humans [94]. Finally, the results concerning continuous exposure to CPF [33] or MAL [41]
during the whole developmental period (gestational and postnatal ages) showed opposing
results characterized by both general enhancement (except for reaction to social novelty in
females) and a significant decrease in social traits, respectively. However, we must point
out that the differences in quality between these studies (MH vs. ML), the chemical studied
(CPF vs. MAL), and the age range of exposure (medium-late gestation to the end of the
second postnatal week vs. early gestation to weaning) prevent us from reaching common
conclusions. Finally—and in relation to exposure to non-OP compounds—all the three
studies included were categorized as MH, and all of them induced an ASD-like phenotype
in their mice, using different doses of both GLA [43,44] or CYP [45] during the whole
developmental period. Once again, the lack of studies limits the generalizability of these
interesting, but insufficient, empirical results.
Based on all this information, we believe that there is not enough empirical support at
any developmental stage or exposure protocol to confidently conclude that exposure to OPs
or other pesticides can be linked to the development of ASD-like (core) behaviors. However,
exposure to CPF during medium gestational ages (around GD12) seems to be the protocol
that shows more promise in this regard [37,38]. This hypothesis gains support when using
other well-known chemicals that can elicit these behavioral alterations when exposed at
this age, as in the case of VPA [95], a drug that has also been linked to the diagnosis of
ASD in humans [13]. However, the results provided by Lan and collaborators [37,38]
must be replicated in other laboratories and in other rodent species such as rats, which are
probably more appropriate models with regard to social outcomes [96], whilst there is also
a need to include models with well-known genetic vulnerabilities to study this complex
gene/environmental relationship that is thought to underlie ASD.
With respect to this last point, it is noteworthy that only two studies included in the
present systematic review used genetic models of ASD (BTBR and heterozygous Reeler
mice) to study behavioral outcomes [35,39] or molecular biomarkers [36], the two former
studies finding enhanced social rates following CPF and CPO exposure. If the current
hypothesis—that pesticides are environmental factors that can unmask or worsen the ASD
phenotype codified in genes of vulnerability—is valid, these preliminary results point
toward another direction, at least in relation to CPF. However, we consider that findings
from a sum total of only two studies, which differ markedly, are an insufficient basis
upon which to draw firm conclusions. We should not overlook the results obtained by
De Felice et al. [35] regarding neuromotor outcomes and later [36] for different molecular
markers that are generally linked to ASD.
4.2. Clinical Studies and ASD
As reported above, a total of 45 clinical studies were finally included in the present
systematic review, 17 of which assessed OP exposure by means of metabolite measures,
with two of the 17 studies assessing TCPy as a measure of CPF exposure [46] as well as other
OP metabolites [60]. Moreover, 11 out of the 45 studies evaluated OC through metabolite
measures, whilst two studied Mirex [72] and Chlordecone exposure [73]. Further, five out
of 45 assessed general PT exposure by means of metabolite measures. CM exposure was
assessed in two out of 45 (Carbofuranphenol, Zhang et al. [79] and Mancozeb, [80], whereas
only Imidacloprid exposure was employed as a measure of NN exposure [81]. Finally,
nine out of 45 studies assessed the effects of exposure to a common mix of pesticides.
Int. J. Environ. Res. Public Health 2021, 18, 5190 22 of 30
As reported above, analyses were separated according to pesticide class (OP, OC,
PT, CM, NN, and mixtures), period of exposure, and assessment outcome. Considering
the studies analyzed assessing OP exposure, 14 out of 17 found effects on cognitive and
behavioral functions after either prenatal or postnatal exposure. In particular, studies that
assessed the effects of prenatal exposure to OP metabolites at very early ages (first days
after delivery) pointed to altered primary reflexes, tone, and behavioral regulation [49,62].
Similarly, VH-quality studies observed alterations in motor function at 5 months [56],
whereas H-quality works observed these alterations at 9 months of age [60]. However,
these studies lack an adequate follow-up to establish future alterations during childhood
or associations with ASD that are more likely to be diagnosed around the age of 18 months
and beyond [97]. In this sense, another study classified as VH-quality [48] found asso-
ciations between prenatal exposure to OPs and alterations in behavioral domains that
could influence social relations, along with impaired social scores in boys evaluated at
two years of age. Accordingly, social deficits among boys (7–9 years) were also found by
Furlong et al. [54] (H-quality), with stronger effects observed in black participants follow-
ing prenatal exposure, while a study classified as VH [58], with the HOME cohort, did not
find any significant associations between OP exposure and autism when their model was
adjusted for maternal sociodemographic and perinatal factors (8 years), with the authors
indicating that a larger sample size might have allowed them to detect certain associations
related to PON1 polymorphisms. Some of the discrepancies in results can be due to dif-
ferences in OP insecticide exposure in the studied population, given that HOME study
enrollment followed the U.S. EPA moves to restrict the residential use of OPs, thus low-
ering the environmental concentrations in comparison with those to which participants
in the Mount Sinai Environmental Health study were exposed [98]. Moreover, another
VH-quality study included in this review did not find any association between prenatal
exposure to OP and ASD or ADHD [61]. The characteristics of the population included in
this study, that is, high socioeconomic level and high levels of exposure mainly through
diet (fresh fruit and vegetables) raise an important question regarding the lifestyle and
social factors that could increase population resilience to toxicant effects. Further, another
study with a long follow-up assessment (from one to 12 years of age) showed childhood
and adolescence autism-related traits to be associated with prenatal OP exposure [59].
In addition, an H-quality study [47] found an association between prenatal OP exposure
and autism diagnosis at three years of age, but in this case, the effects were only observed
in girls. This study is one of the few that uses clinical diagnoses of autism instead of
behavioral traits associated with social or communication abilities. Even though the quality
of the study is high, the use of a population that is at high risk for ASD may have had some
influence on this result. More studies are thus needed to assess OP effects on populations
at high risk for ASD.
Moreover, studies categorized as VH-quality also found cognitive and developmen-
tal delays in children prenatally exposed to OP at two years of age [53,57] as well as
neuropsychological impairments at later ages [50,52].
Regarding early postnatal exposure, VH-quality studies found social impairments
among boys at two years of age [57], with similar results being reported by Guo et al. [46]
related to CPF exposure at three years of age, whilst Wang et al. [48] reported some changes
in the adaptive domain. Moreover, an H-quality study reported neuropsychological
impairments associated with postnatal exposures [55].
With regard to OC exposure, 7 out of 11 studies found some cognitive but not so-
cial adverse effects in children exposed prenatally or postnatally to this type of pesticide.
Two VH-quality studies reported autistic behaviors associated with blood OC metabolite
levels [64,66]. All of these use a prenatal exposure protocol, evaluated at early ages (between
two and four months of age) [64] and from four to five years of age [66]. In addition, a study
using prenatal exposure with a follow-up period between one and five years reported
intelligibility, vocabulary comprehension, and production deficits [67], while verbal com-
prehension, memory, and cognitive problems were observed by Torres-Sánchez et al. [71].
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Similarly, cognitive deficits, particularly in working memory and quantitative areas were
observed at four years of age following Mirex exposure [72], while Chlordecone exposure
was linked to poorer motor ability amongst boys [73]. The same motor and cognitive
deficits were also observed in children aged between eight and twelve months following
postnatal exposure, in a study categorized as H quality [68].
Conversely, the residential uses of PT have been rapidly increasing over the years [99].
In this review, except for the study by Watkins et al. [78] (H-quality), all studies were
categorized as VH-quality. Moreover, all the included studies showed behavioral or
development deficits, being more evident in the two studies which evaluated postnatal
exposure. Prenatal exposure to PT was associated with mental but not motor development
problems in children between two and three years of age [77,78]. Children aged up to three
years showed behavioral and emotional deficits [74], while the PELAGIE cohort showed
an increased risk of behavioral disorders [76], in addition to verbal comprehension and
working memory deficits after postnatal exposures [75]. These results are in accordance
with those reported by Oulhote and Bouchard [100], who also found behavioral problems
in children. In any case, the literature on PTs is scarce, and more longitudinal investigations
are needed to verify these findings.
Likewise, all studies that assessed exposure to mixed or different types of pesticides
were classified as VH-quality. Moreover, only one study did not find any association with
autism symptomology after postnatal mixed exposure. Regarding prenatal exposure to
some pesticides mentioned above (CPF, MAL, Diazinon, Avermectin, and Permethrin)
appears to be associated with autistic behaviors in children assessed during their first
year of life [83]. The same results were observed in the CHARGE cohort exposed to OP
and PT [90] in addition to CM and NN [81,89]. Interestingly, Schmidt and coworkers [89]
reported a decreased risk of the disorder when mothers received FA supplements during
pregnancy. It has previously been reported that FA intake prevents neurodevelopmental
and behavioral outcomes such as hyperactivity or verbal deficits, amongst others [101,102].
Accordingly, in a case-control study conducted by the same authors, it was found that
gestational FA supplements near the time of conception were associated with a reduction
in ASD risk (around 40%) [103]. Moreover, socio-emotional deficits were found after PT
exposure at one year of age, as well as communication and language problems among girls,
while at two years of age this deficit was observed in both sexes. Similar communicative
deficits were observed at two years of age after OC metabolite exposure, followed by
motor problems [84]. The same outcomes were observed in girls when they were evaluated
between six and 11 years of age, whilst impairments in neurobehavioral and cognitive
functions were also observed in this sex [82]. In addition, Furlong et al. [74] found cognitive
problems among black children, as well as internalizing deficits after OC exposure. In a
similar vein, Gunier et al. [91] found deficits in IQ and comprehension as well as perceptual
reasoning problems following OP, PT, and NN exposure, whilst combined OP and CM
exposure was only associated with IQ deficits [91]. Prenatal exposure to only carbamates
(Mancozeb) at one year of age was associated with cognitive problems among girls, motor
and language deficits in boys, and lower socio-emotional scores in both sexes [80]. Further,
when studying the effects of exposure at two years of age (Propoxur), Ostrea et al. [88]
only found motor problems in boys, whilst at three years of age prenatal and postnatal
Carbofuranphenol exposure was found to be associated with social behavior deficits [79].
Taking together, all of this information suggests that there are certain discrepancies
in the way in which autism is assessed, with some studies relying on clinical diagnoses
of autism whilst others use scale scores to obtain data related to the symptomatology of
ASD, which are also shared with other multiple neurodevelopmental disorders such as
depression and mood disorders [54]. Moreover, other discrepancies could be related to
the substantial variability between studies when assessing the source, route, and period
of exposure. Many of the studies assessed exposure through metabolite levels in urine or
blood, while others assessed specific compounds such as CPF or MAL. The presence of
metabolites in urine may not be exclusively a result of environmental exposure, and in
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fact, these compounds could be ingested through the diet by humans; therefore, metabolite
measures reflect exposure by both environmental and dietary routes [104]. In a similar vein,
metabolite evaluation makes it difficult to conclude, because some of these biomarkers
are nonspecific (e.g., DAPs or 3-PBA) and instead they arise from a multiple range of
compounds with varying levels of toxicity and potency [98]. Further, it is also worth
noting that studies conducted in different countries use different compounds and levels of
exposure, which could explain some of the discrepancies between results [49,62].
Another challenge is that humans are constantly exposed to a wide variety of pesticides
(through diet, house fumigation, or agricultural exposure), but most of the authors reported
the effects of exposure to a single pesticide since they studied only a limited number of
metabolites. It must also be taken into account that diet could have a pronounced impact
on the outcomes observed in children. Diet is a strong variable, and, along with its inherent
importance as the source of nutrients and vitamins, it is also associated with socioeconomic
status. It remains unclear as to whether the consumption of fresh fruit and vegetables
could partially counteract the adverse effects produced by pesticides, or whether there are
potential beneficial effects of a diet supplemented with FA [89,103]. Moreover, some studies
reported a stronger association between ASD or their symptomatology and sex. Although
boys are almost four times more likely than girls to be diagnosed with autism [105],
the results did not suggest the existence of a stronger association among boys, since an
equal number of studies reported effects among girls. This indicates that environmental
factors could equally affect both sexes. Alternatively, other studies find autism-related
traits in children of black and unmarried women, thus highlighting the influence of other
factors such as diet, vitamin deficiencies, socioeconomic status, or genetics [24].
Another important issue is related to the age at which the outcomes are evaluated
since studies assessing behavior at very early stages found more adverse effects than those
using a longer follow-up period. It appears that early detection of autism (one or two-week
evaluations) can be extremely valuable for detection, prevention, and establishing more
effective treatments [106].
4.3. Relationship between Preclinical and Clinical Studies Concerning ASD
Comparisons between the preclinical and clinical results summarized in the present
systematic review can be made only with regard to OP compound exposure as the re-
maining families of pesticides have not been systematically studied using animal models.
However, the type of compound differs among these studies; since animal studies are more
focused on CPF exposure, whilst human studies focus on non-specific OP metabolites.
As previously described, preclinical studies have yielded inconsistent results, but exposure
during specific gestational ages (around GD12) has the strongest empirical support. Thus,
in clinical studies, it is difficult to conclude because of the considerable variability observed
in terms of age or type of exposure. Nonetheless, it seems that exposure to OP during
prenatal or early postnatal periods is associated with cognitive and social deficits, OC ex-
posure is linked to adverse effects on cognition, and PT exposure is linked to behavioral
problems. Therefore, we can conclude that studies conducted in animals included more
stable and controlled parameters than those conducted in humans.
5. Conclusions
This review provides a comprehensive synthesis of the available evidence from various
sources and evaluates the link between exposure to a wide range of pesticides and ASD
and associated symptomatology. Our search, however, revealed that OCs have been the
most widely studied type of pesticides to date. In particular, the review of preclinical
studies highlights that:
- The relation between exposure to different pesticides and the ASD-like phenotype con-
cerning the core symptomatology of autism is relatively under-explored in preclinical
research. Even in the case of those compounds for which there is a significant amount
of empirical research regarding sociability and/or communicative outcomes (e.g.,
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CPF), the considerable differences between studies regarding exposure protocols (e.g.,
gestational vs. postnatal or early vs. medium vs. late gestational) make it impossible,
in the end, for us to draw any solid conclusions.
- There is a significant gap in the literature as only one study included in the review
used rats. Although the relevance of the use of mice is unquestionable, it is known
that rat models are closer to humans in terms of genetic background and behavioral
regulation, particularly with regard to social behaviors [96].
- Future preclinical research should focus on a more in-depth analysis of exposure to
developmental CPF and other pesticides concerning the core (sociability and USVs)
and secondary (e.g., neuromotor development) clinical signs of ASD, with a special
emphasis on the gestational period around GD12, whilst it will also be necessary to
include rat models along with the work carried out with mice.
- The study on wild-type mice should be complemented with the systematic analyses of
the interactions of this exposure with the various genetic backgrounds of vulnerability
associated with the ASD-like phenotype.
In relation to clinical studies:
- It is difficult to draw solid conclusions as there are a wide variety of studies that differ
in many aspects such as route, age, or source of exposure.
- The study of exposure to a single pesticide in humans lacks ecological validity, due to
the fact that humans are constantly exposed to a wide range of pesticides through a
range of routes such as diet, house fumigation, or agriculture. This wide variability
of compounds and environmental exposure could contribute to the heterogeneity of
results found in the literature.
- Pesticide exposure appears to co-exist with other factors that may be harmful or
beneficial for the development of the nervous system. Examples of other factors that
could explain the association between pesticides and ASD are lifestyle, socioeconomic
or educational status as well as ethnicity or gender. Moreover, maternal age is an
important factor to consider, as the concentration of pesticides in the body increases
with age, and so higher maternal ages are more strongly associated with an increased
risk of autism in their offspring [107].
- Pesticide exposure did not always show harmful effects when authors considered
different covariates, suggesting the existence of certain genetic polymorphisms which
could interact with environmental factors and amplify the adverse effects of pesticides
in relation to ASD (gene-environment interaction).
- Further clinical research is needed to homogenize exposure in human studies, partic-
ularly in terms of exposure to specific pesticides, consideration of other risk factors,
as well as the use of a more well-defined follow-up period and validated tools for
measuring behavioral outcomes.
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